Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

42.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
42.8K
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

2.3K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.3K
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

4.1K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.1K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

974
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
974
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

399
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
399
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

597
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
597

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA Cohort.

Open forum infectious diseases·2026
Same author

Healthcare Resource Consumption and Related Costs of People Living with HIV and Antiviral Treatment: A Retrospective Observational Study in Italy.

Diseases (Basel, Switzerland)·2026
Same author

96-week real-world effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in HIV-infected adults with pre-existing NRTI resistance: A retrospective cohort study.

Journal of global antimicrobial resistance·2025
Same author

Comparable gut mucosal breakdown and microbial translocation in severe COVID-19 with and without HIV infection.

AIDS (London, England)·2025
Same author

Question and answers on long-acting therapy with cabotegravir and rilpivirine in people with HIV.

The Journal of antimicrobial chemotherapy·2025
Same author

Adherence and Forgiveness of Two Modern ART Regimens: Lamivudine/Dolutegravir and Emtricitabine/Tenofovir Alafenamide/Rilpivirine.

Journal of acquired immune deficiency syndromes (1999)·2025

Related Experiment Video

Updated: Apr 25, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

20.3K

Single-Tablet Regimens in HIV Therapy.

Noemi Astuti1, Franco Maggiolo

  • 1Unit of Antiviral Therapy, Division of Infectious Diseases, AO Papa Giovanni XXIII, Bergamo, Italy.

Infectious Diseases and Therapy
|August 20, 2014
PubMed
Summary

Simplified antiretroviral therapy regimens improve adherence and quality of life for HIV patients. Single-tablet regimens (STRs) offer better adherence and tolerability, with new options emerging for long-lasting treatment efficacy.

Area of Science:

  • Virology and Immunology
  • Pharmacology and Therapeutics
  • Public Health and Epidemiology

Background:

  • Combined antiretroviral therapy (cART) has advanced HIV management.
  • Regimen simplification aims to enhance patient adherence and quality of life.
  • Non-adherence to cART is linked to patient and regimen-specific factors.

Purpose of the Study:

  • To review the evolution and benefits of simplified antiretroviral therapy (ART) regimens.
  • To highlight the role of single-tablet regimens (STRs) in improving adherence and patient outcomes.
  • To discuss current and future developments in ART simplification.

Main Methods:

  • Literature review of studies on cART simplification and adherence.
  • Analysis of guidelines recommending ART regimen simplification.

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.2K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.2K

Related Experiment Videos

Last Updated: Apr 25, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

20.3K
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.2K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.2K
  • Evaluation of efficacy, safety, and tolerability data for available STRs.

    • Main Results:

    • Once-daily (OD) regimens with reduced pill burden significantly increase adherence rates.
    • STRs reduce selective non-adherence and are associated with improved quality of life (QoL).
    • Current STRs demonstrate excellent efficacy and improved safety/tolerability profiles.

    Conclusions:

    • ART simplification, particularly through STRs, is crucial for long-lasting HIV treatment efficacy.
    • Patient preference, adherence, and QoL are key factors in successful long-term cART.
    • Future research should focus on developing novel STRs for diverse patient populations, including heavily pre-treated individuals.